These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 6189191)

  • 1. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 2. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of chemotherapy in the management of early stage Hodgkin's disease.
    Rosenberg SA
    Hematol Oncol; 1984; 2(1):61-3. PubMed ID: 6203821
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Ekert H
    Cancer Treat Res; 1989; 41():241-6. PubMed ID: 2484293
    [No Abstract]   [Full Text] [Related]  

  • 6. Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
    Tombolini V; Capua A; Pompili E
    Acta Oncol; 1992; 31(1):64-5. PubMed ID: 1375043
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
    Jones SE; Haut A; Weick JK; Wilson HE; Grozea P; Fabian CJ; McKelvey E; Byrne GE; Hartsock R; Dixon DO; Coltman CA
    Cancer; 1983 Apr; 51(8):1339-47. PubMed ID: 6186355
    [No Abstract]   [Full Text] [Related]  

  • 8. Hodgkin's disease: controversies and challenges for the future.
    Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
    Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
    [No Abstract]   [Full Text] [Related]  

  • 9. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Canellos GP
    Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternating drug combinations for advanced Hodgkin's disease.
    N Engl J Med; 1982 Sep; 307(11):687-9. PubMed ID: 6180317
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy for advanced Hodgkin's disease.
    Choudhry VP
    Indian J Pediatr; 1982; 49(401):823-5. PubMed ID: 6189783
    [No Abstract]   [Full Text] [Related]  

  • 12. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 13. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 14. Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
    Bonadonna G; Santoro A; Viviani S; Lombardi C; Ragni G
    Arch Toxicol Suppl; 1984; 7():140-5. PubMed ID: 6083763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABVD chemotherapy in the treatment of Hodgkin's disease.
    Bonadonna G; Santoro A
    Cancer Treat Rev; 1982 Mar; 9(1):21-35. PubMed ID: 6175409
    [No Abstract]   [Full Text] [Related]  

  • 16. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer; 1983 Apr; 51(8):1348-52. PubMed ID: 6186356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of Hodgkin's disease].
    Amiel JL; Mathé G
    Rev Prat; 1974 Oct; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Busia A; Laffranchi A; Viviani S; Bonfante V; Villani F
    Anticancer Res; 2010 Oct; 30(10):4381-7. PubMed ID: 21036768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than MOPP for advanced Hodgkin's disease?
    Mayer RJ
    N Engl J Med; 1982 Apr; 306(13):800-2. PubMed ID: 6174866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.